Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lycosome-formulated simvastatin for hypercholesterolemia and atherosclerosis
ACTRN12615000357550Phase 2Recruiting
- Sponsor
- Lycotec
- Start
- Feb 2015
- Modality
- Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 2
01
Overview
Phase 2, open-label trial of simvastatin and lycopene in hypercholesterolemia, hyperlipidemia, atherosclerosis and 2 more (3 arms), sponsored by Lycotec. Started Feb 2015; status: recruiting.
02
Drugs
simvastatinlycopene
03
Conditions
hypercholesterolemiahyperlipidemiaatherosclerosiscoronary arteriosclerosiscardiac morbidity
Beyond the preview
Go deeper on ACTRN12615000357550.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12615000357550.